Patent · US Expired

Use of von willebrand factor and pharmaceutical formulation

US6005077A · kind A · utility

19Cited by

4References

15Claims

0Family size

Assignee

Immuno Aktiengesellschaft · AT

Inventors

Hans-Peter Schwarz · Wien, AT
Peter Turecek · Klosterneuburg, AT
Johann Eibl · Wien, AT

Key dates

Filing date	Nov 6, 1996
Grant date	Dec 21, 1999
Priority date	—
Expiry date	Nov 6, 2016

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/755
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of von Willebrand Factor (vWF) with a prolonged biological half-life for the production of a preparation for stabilization of blood coagulation Factor VIII (FVIII:C) in a mammal. Additionally, a pharmaceutical preparation is provided comprising a biologically active FVIII:C/vWF complex with improved pharmokinetic properties, said complex containing a vWF with a prolonged biological half-life.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.